Satellos Bioscience Inc. (MSLE)
Last updated: 2026-10-27 10:29:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Satellos Bioscience Inc. (MSLE) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $6.55, with a market capitalization of $136.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.44 to $13.39. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$136.21M | |
$6.42 | |
$13.39 | |
$5.44 | |
$6.42 | |
56.30K | |
41.32K | |
-- | |
$13.39 | |
$5.44 | |
-- | |
-- |
Satellos Bioscience Inc. (MSLE) Pre-Market Stock Price
Satellos Bioscience Inc. (MSLE) is trading at $6.42 in pre-market trading as of 2026-10-26 23:31:00, unchanged from the previous close of $6.42
Pre-market trading shows how investors are pricing MSLE before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.
Satellos Bioscience Inc. (MSLE) 7-Day Stock Price Change
Over the past seven days, Satellos Bioscience Inc. (MSLE) moved from $6.46 to $6.55, representing a gain of 1.36% ($0.09).
The stock traded between $6.26 and $7.12 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 28.06 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
MSLE 52-Week Price Position
Position in Range: 13.9%
MSLE is currently trading at $6.55, placing it 13.9% of the way from its 52-week low of $5.44 to its 52-week high of $13.39. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Satellos Bioscience Inc. (MSLE)?
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
Satellos Bioscience Inc. Information
| Employees | 21 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Satellos Bioscience Inc. (MSLE) Stock on MEXC
Eligible investors can buy real shares of Satellos Bioscience Inc. (MSLE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Satellos Bioscience Inc. (MSLE) stock price today?
2.Is MSLE stock going up or down today?
3.What is MSLE pre-market price?
4.What is MSLE after-hours price?
5.Is MSLE stock trading now?
6.Where does MSLE sit relative to its 52-week high and low?
7.What sector is Satellos Bioscience Inc. in?
8.What is Satellos Bioscience Inc.'s market capitalization and where is it listed?
9.How is MSLE valued in terms of P/E ratio and EPS?
10.Does Satellos Bioscience Inc. pay a dividend?
Explore More US Stocks
Search Stocks
MSLE Stock Calculator
Estimate the value between MSLE shares and USD.
MSLE Shares to USD
1.00 MSLE shares = 6.548 USD
Calculations are estimates based on the latest available price and are for reference only.



